Eureka Therapeutics is a biotechnology company that develops and commercializes immunotherapies for the treatment of cancer. The company's proprietary technology platform, called ARTEMIS, enables the development of T-cell therapies that target solid tumors. Eureka Therapeutics was founded in 2015 and is headquartered in Berkeley, California.